SUMOylation has been associated with advanced staging and high-risk genetic mutations like c-Myc rearrangement and high-grade B-cell Non-Hodgkin lymphoma (NHL) (26, 57). The gene discussed is MYC; the disease is non-Hodgkin lymphoma.